Abstract:Objective: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern because of its propensity for rapid deterioration and high mortality. Its aetiology and mechanism are still unclear. The aims of this study were to clarify the pathophysiology differences between AE-IPF and stable IPF (S-IPF) by comparing the serum levels of various cytokines and chemokines in the two groups and to identify those involvement in the occurrence of acute exacerbation and associated with mortality. Methods: The study included 28 patients with AE-IPF, 32 patients with S-IPF, and 18 healthy control subjects. We measured the serum cytokine and chemokine levels in all cases by multiplex assay. Serum levels of cytokines and chemokines were compared between AE-IPF and S-IPF subjects. Logistic regression analysis was applied to identify the ability of these variables to predict acute exacerbation. Kaplan-Meier curves were used to analyse survival and Cox proportional hazard regression was used to identify predictors of survival. Results: Levels of several cytokines and chemokines were significantly higher in both patient groups with IPF (with the exception of interleukin-2 [IL-2], chemokine cc-motif ligand 3, and RANTES [regulation upon activation normal T-cell express sequence]) than in healthy controls. Serum IL-1 beta (p = 0.008) and interferon (IFN)-gamma (p = 0.007) levels tended to be higher in patients with AE-IPF than in those with S-IPF. The concentration of chemokine cc-motif ligand (CCL) 2 was significantly higher in bronchoalveolar lavage fluid than in serum (p = 0.001). Higher C-reactive protein, lactate dehydrogenase, percent forced vital capacity, percent diffusing capacity of the lung for carbon monoxide, and IFN-gamma values in the patients with IPF were correlated with acute exacerbation status, with respective odds ratios of 1.241 (p = 0.011), 1.050 (p = 0.004), 1.043 (p = 0.001), 0.927 (p = 0.014), and 0.929 (p = 0.020). Acute exacerbation status was associated with an increased risk of mortality (hazard ratio 0.107, 95% confidence interval 0.036-0.314; p < 0.001). Univariate Cox regression demonstrated an association of IFN-gamma, CCL2, C-X-C motif chemokine 10 (CXCL10) and sCD163 levels with an increased mortality risk (p = 0.015, p = 0.002, p = 0.001, and p = 0.030, respectively). Conclusions: Our data demonstrate that serum levels of some pro-inflammatory cytokines and macrophage chemokines are upregulated during acute exacerbations of IPF and that these exacerbations are associated with the serum IFN-gamma level. Chemokines and protein such as sCD163, CCL2, and CXCL10 are associated with activation of macrophages and may have a serious impact on overall survival in patients with IPF.

Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.

An Essential Role for Stat3 in Regulating Igg Immune Complex-Induced Pulmonary Inflammation

Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease

Beyond innate immunity: the role of interferon regulatory factor 3 in CD4+ T cell function (IRM15P.462)

IRF3 inhibits inflammatory signaling pathways in macrophages to prevent viral pathogenesis

Association of Respiratory Syncytial Virus Toll-Like Receptor 3-Mediated Immune Response with COPD Exacerbation Frequency

Macrophages-derived Factor XIII links coagulation to inflammation in COPD

IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer’s disease

Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice

AIM2 Inflammasome Activation Leads to IL-1α and TGF-β Release From Exacerbated Chronic Obstructive Pulmonary Disease-Derived Peripheral Blood Mononuclear Cells

Th17/Treg imbalance in COPD development: suppressors of cytokine signaling and signal transducers and activators of transcription proteins

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease

Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation

Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium

Activating Transcription Factor 3 Represses Cigarette Smoke-Induced IL6 and IL8 Expression Via Suppressing NF-κB Activation.

Activator protein transcription factors coordinate human IL-33 expression from noncanonical promoters in chronic airway disease

RTN3 interacting with CRTH2 regulates collagen biosynthesis and profibrotic macrophage differentiation to promote pulmonary fibrosis

Prognostic Value of IFN-γ, Scd163, CCL2 and CXCL10 Involved in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

[The Study of Inflammatory Mediators and Pulmonary Ventilatory Capacity in Patients with Chronic Obstructive Pulmonary Disease].

Imbalance Between Subpopulations of Regulatory T Cells in Copd